Arteris (NASDAQ:AIP) VP Sells $51,550.00 in Stock

Key Points

• Arteris VP Paul Alpern sold 5,000 shares of the company's stock for $51,550, marking a 6.36% decrease in his total holdings.
• The company's stock value dropped by 2.5% recently, trading at $10.98, while the market capitalization stands at $468.30 million.
• Analysts have varying opinions on Arteris, with TD Cowen issuing a "buy" rating and increasing the price target to $15.00, while Weiss Ratings maintains a "sell" rating.

Arteris, Inc. (NASDAQ:AIP - Get Free Report) VP Paul Alpern sold 5,000 shares of the company's stock in a transaction that occurred on Wednesday, October 1st. The stock was sold at an average price of $10.31, for a total transaction of $51,550.00. Following the completion of the transaction, the vice president owned 73,587 shares in the company, valued at approximately $758,681.97. This represents a 6.36% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Arteris Trading Down 2.5%

NASDAQ AIP traded down $0.28 on Friday, hitting $10.98. 394,921 shares of the company traded hands, compared to its average volume of 545,253. The company has a market capitalization of $468.30 million, a price-to-earnings ratio of -13.39 and a beta of 1.45. Arteris, Inc. has a 52-week low of $5.46 and a 52-week high of $14.29. The business's 50 day moving average price is $9.61 and its 200-day moving average price is $8.40.

Arteris (NASDAQ:AIP - Get Free Report) last released its quarterly earnings data on Tuesday, August 5th. The company reported ($0.11) EPS for the quarter, meeting the consensus estimate of ($0.11). Arteris had a negative net margin of 52.41% and a negative return on equity of 8,546.17%. The business had revenue of $16.50 million during the quarter, compared to the consensus estimate of $16.35 million. Arteris has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, sell-side analysts predict that Arteris, Inc. will post -0.73 earnings per share for the current year.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the stock. TD Cowen upped their price objective on shares of Arteris from $12.00 to $15.00 and gave the company a "buy" rating in a report on Wednesday, August 6th. Weiss Ratings reissued a "sell (d-)" rating on shares of Arteris in a report on Saturday, September 27th. Finally, Wall Street Zen upgraded shares of Arteris from a "sell" rating to a "hold" rating in a research report on Monday, September 15th. Three equities research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $15.00.

Institutional Investors Weigh In On Arteris

A number of large investors have recently added to or reduced their stakes in AIP. Acadian Asset Management LLC grew its holdings in Arteris by 40.6% in the first quarter. Acadian Asset Management LLC now owns 900,723 shares of the company's stock valued at $6,222,000 after purchasing an additional 260,277 shares during the period. AQR Capital Management LLC purchased a new position in shares of Arteris in the first quarter valued at $1,621,000. Federated Hermes Inc. increased its position in shares of Arteris by 97.2% during the first quarter. Federated Hermes Inc. now owns 327,119 shares of the company's stock worth $2,260,000 after acquiring an additional 161,241 shares during the last quarter. Franklin Resources Inc. boosted its stake in shares of Arteris by 9.6% during the 2nd quarter. Franklin Resources Inc. now owns 1,637,171 shares of the company's stock valued at $15,602,000 after buying an additional 142,936 shares during the last quarter. Finally, Next Century Growth Investors LLC increased its position in shares of Arteris by 46.4% in the 1st quarter. Next Century Growth Investors LLC now owns 407,721 shares of the company's stock worth $2,817,000 after purchasing an additional 129,143 shares during the last quarter. 64.36% of the stock is owned by institutional investors and hedge funds.

About Arteris

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.